Release of the Eudra Vigilance Data Warehouse and

  • Slides: 23
Download presentation
Release of the Eudra. Vigilance Data Warehouse and Analysis System (EVDAS) to National Competent

Release of the Eudra. Vigilance Data Warehouse and Analysis System (EVDAS) to National Competent Authorities in Member States Stefano Cappe Pharmacovigilance and Post-Authorisation Safety and Efficacy of Medicines EMEA, EU www. diahome. org

Summary • • • EVDAS Release of EVDAS to NCAs Functionalities included Training of

Summary • • • EVDAS Release of EVDAS to NCAs Functionalities included Training of NCAs Next steps www. diahome. org

EVDAS (I) • The Eudra. Vigilance Data Analysis System is a database for: –

EVDAS (I) • The Eudra. Vigilance Data Analysis System is a database for: – Answering pharmacovigilance queries – Collecting and integrating data from a variety of Source Systems – Containing cleaned and consolidated data – Preserving historical data www. diahome. org

EVDAS (II) Data Analysis Adverse Reactions (ICSRs) ETL Medicinal Products (EVMPD) Eudra. Vigilance Data

EVDAS (II) Data Analysis Adverse Reactions (ICSRs) ETL Medicinal Products (EVMPD) Eudra. Vigilance Data Warehouse User and Organisations Med. DRA and Standard Terminology Data Collection – Source systems www. diahome. org

Release of EVDAS to NCAs • The system has been released in July 2007

Release of EVDAS to NCAs • The system has been released in July 2007 to: – EMEA internal users – National Competent Authorities (NCAs) www. diahome. org

EVDAS functionalities • Administrative queries – Number of ICSRs transmitted – Expedited reporting timelines

EVDAS functionalities • Administrative queries – Number of ICSRs transmitted – Expedited reporting timelines www. diahome. org

EVDAS functionalities • Pharmacovigilance queries – – – – Drug/Reaction Reports Static PRR Reports

EVDAS functionalities • Pharmacovigilance queries – – – – Drug/Reaction Reports Static PRR Reports Dynamic PRR Reports Reaction Monitoring Reports Clinical Trials Reports Patient Age/Sex Reports Med. DRA Dictionary Reports Product Dictionary Reports www. diahome. org

Number of ICSRs transmitted Safety report received monthly by EMEA (PM top – CT

Number of ICSRs transmitted Safety report received monthly by EMEA (PM top – CT bottom) www. diahome. org

Expedited reporting timelines - NCAs Reference period 1 April 2007 - 30 September 2007

Expedited reporting timelines - NCAs Reference period 1 April 2007 - 30 September 2007 www. diahome. org

Expedited reporting timelines - MAHs Reference period 1 April 2007 - 30 September 2007

Expedited reporting timelines - MAHs Reference period 1 April 2007 - 30 September 2007 www. diahome. org

Drug-reaction report This report is used to check the frequency of drug/reaction combinations in

Drug-reaction report This report is used to check the frequency of drug/reaction combinations in EVDAS www. diahome. org

Static PRR reports Signal highlighted for: PRR 95% LB >1 & COUNT>=3 Signal highlighted

Static PRR reports Signal highlighted for: PRR 95% LB >1 & COUNT>=3 Signal highlighted for: PRR>2 & CHI^2>4 & COUNT>=3 www. diahome. org

Static PRR report (graph) Signal highlighted if the box is all included in the

Static PRR report (graph) Signal highlighted if the box is all included in the area marked in yellow www. diahome. org

Static PRR report (Med. DRA) Calculation of PRR performed jointly at all levels of

Static PRR report (Med. DRA) Calculation of PRR performed jointly at all levels of the Med. DRA hierarchy Signal highlighted for: PRR 95% LB>1 & COUNT>=3 www. diahome. org

PRR Dynamic Signal highlighted if the lower line (PRR 95% LB) enters in area

PRR Dynamic Signal highlighted if the lower line (PRR 95% LB) enters in area marked in yellow www. diahome. org

Reaction monitoring report New A reaction is displayed in the report only if a

Reaction monitoring report New A reaction is displayed in the report only if a new ICSR is received in the monitoring period (“New”) Start Monitoring www. diahome. org Today

Clinical Trial Monitoring of clinical trials ongoing by EUDRACT Number It is possible to

Clinical Trial Monitoring of clinical trials ongoing by EUDRACT Number It is possible to drill to the list of reactions in the trials www. diahome. org

Patient Age/Sex Reports Number of cases (y – axis) by age (x – axis)

Patient Age/Sex Reports Number of cases (y – axis) by age (x – axis) grouped by sex www. diahome. org

Med. DRA Dictionary Reports It works as a Med. DRA browser in EVDAS, it

Med. DRA Dictionary Reports It works as a Med. DRA browser in EVDAS, it also allows to browse the Standard Med. DRA Queries (SMQs) www. diahome. org

Training of NCAs • Users need to receive appropriate training before accessing EVDAS •

Training of NCAs • Users need to receive appropriate training before accessing EVDAS • Training of NCAs is ongoing: – 4 training courses have been organised (status 1 st October 2007) – 55 NCA users have been trained www. diahome. org

Next Training Dates • Next training dates available for NCAs: – 8 – 10

Next Training Dates • Next training dates available for NCAs: – 8 – 10 October – 22 – 24 October • Training dates for Marketing Authorisation Holders will be planned once the Access Policy in Eudra. Vigilance has been approved and implemented in EVDAS www. diahome. org

Next steps • Access to MAHs/Healthcare Professionals/General public • Additional Analyses – Stratification Analysis

Next steps • Access to MAHs/Healthcare Professionals/General public • Additional Analyses – Stratification Analysis for PRR – Medicinal product interactions – Integration of Risk Management Plans – Integration of Signal Tracking Tool www. diahome. org

Questions? www. diahome. org

Questions? www. diahome. org